URANIUM ENERGY CORP (U6Z.DE) Fundamental Analysis & Valuation

FRA:U6Z • US9168961038

Current stock price

12.37 EUR
-0.42 (-3.28%)
Last:

This U6Z.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. U6Z.DE Profitability Analysis

1.1 Basic Checks

  • U6Z had negative earnings in the past year.
  • In the past year U6Z has reported a negative cash flow from operations.
  • In the past 5 years U6Z reported 4 times negative net income.
  • U6Z had negative operating cash flow in 4 of the past 5 years.
U6Z.DE Yearly Net Income VS EBIT VS OCF VS FCFU6Z.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

  • U6Z has a Return On Assets of -5.32%. This is amonst the worse of the industry: U6Z underperforms 86.96% of its industry peers.
  • With a Return On Equity value of -5.77%, U6Z is not doing good in the industry: 84.06% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -5.32%
ROE -5.77%
ROIC N/A
ROA(3y)-3.88%
ROA(5y)-3.78%
ROE(3y)-4.4%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
U6Z.DE Yearly ROA, ROE, ROICU6Z.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30 -40 -50

1.3 Margins

  • U6Z has a Gross Margin (49.64%) which is in line with its industry peers.
  • U6Z's Gross Margin has improved in the last couple of years.
  • U6Z does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.16%
GM growth 5YN/A
U6Z.DE Yearly Profit, Operating, Gross MarginsU6Z.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5K -10K -15K -20K -25K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. U6Z.DE Health Analysis

2.1 Basic Checks

  • U6Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • U6Z has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for U6Z has been increased compared to 5 years ago.
  • There is no outstanding debt for U6Z. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
U6Z.DE Yearly Shares OutstandingU6Z.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
U6Z.DE Yearly Total Debt VS Total AssetsU6Z.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 36.76 indicates that U6Z is not in any danger for bankruptcy at the moment.
  • U6Z has a Altman-Z score of 36.76. This is amongst the best in the industry. U6Z outperforms 97.10% of its industry peers.
  • There is no outstanding debt for U6Z. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 36.76
ROIC/WACCN/A
WACC8.99%
U6Z.DE Yearly LT Debt VS Equity VS FCFU6Z.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 28.72 indicates that U6Z has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 28.72, U6Z belongs to the top of the industry, outperforming 97.10% of the companies in the same industry.
  • A Quick Ratio of 24.65 indicates that U6Z has no problem at all paying its short term obligations.
  • U6Z has a better Quick ratio (24.65) than 97.10% of its industry peers.
Industry RankSector Rank
Current Ratio 28.72
Quick Ratio 24.65
U6Z.DE Yearly Current Assets VS Current LiabilitesU6Z.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. U6Z.DE Growth Analysis

3.1 Past

  • The earnings per share for U6Z have decreased strongly by -14.55% in the last year.
  • Looking at the last year, U6Z shows a very negative growth in Revenue. The Revenue has decreased by -69.78% in the last year.
  • The Revenue has been growing by 42.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-14.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.01%
Revenue 1Y (TTM)-69.78%
Revenue growth 3Y42.37%
Revenue growth 5YN/A
Sales Q2Q%-59.4%

3.2 Future

  • Based on estimates for the next years, U6Z will show a very strong growth in Earnings Per Share. The EPS will grow by 34.42% on average per year.
  • Based on estimates for the next years, U6Z will show a very strong growth in Revenue. The Revenue will grow by 37.88% on average per year.
EPS Next Y33.33%
EPS Next 2Y35.81%
EPS Next 3Y57.51%
EPS Next 5Y34.42%
Revenue Next Year-48.87%
Revenue Next 2Y27.94%
Revenue Next 3Y59.87%
Revenue Next 5Y37.88%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
U6Z.DE Yearly Revenue VS EstimatesU6Z.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
U6Z.DE Yearly EPS VS EstimatesU6Z.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. U6Z.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • U6Z reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for U6Z. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
U6Z.DE Price Earnings VS Forward Price EarningsU6Z.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400 -500

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
U6Z.DE Per share dataU6Z.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as U6Z's earnings are expected to grow with 57.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.81%
EPS Next 3Y57.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. U6Z.DE Dividend Analysis

5.1 Amount

  • No dividends for U6Z!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

U6Z.DE Fundamentals: All Metrics, Ratios and Statistics

URANIUM ENERGY CORP

FRA:U6Z (4/28/2026, 5:25:12 PM)

12.37

-0.42 (-3.28%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-10
Earnings (Next)06-01
Inst Owners79.3%
Inst Owner ChangeN/A
Ins Owners1.55%
Ins Owner ChangeN/A
Market Cap6.06B
Revenue(TTM)20.20M
Net Income(TTM)-81.54M
Analysts78.46
Price Target16.8 (35.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.87%
Min EPS beat(2)25.74%
Max EPS beat(2)56%
EPS beat(4)2
Avg EPS beat(4)-24.45%
Min EPS beat(4)-131.02%
Max EPS beat(4)56%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-20%
Min Revenue beat(2)-100%
Max Revenue beat(2)60%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.83%
PT rev (3m)20.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)-18.31%
EPS NY rev (3m)-11.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-43.55%
Revenue NY rev (1m)-28.97%
Revenue NY rev (3m)-23.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 352.7
P/FCF N/A
P/OCF N/A
P/B 5.04
P/tB 10.18
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.04
BVpS2.45
TBVpS1.22
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -5.32%
ROE -5.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.64%
FCFM N/A
ROA(3y)-3.88%
ROA(5y)-3.78%
ROE(3y)-4.4%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.16%
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 133.6%
Cap/Sales 25.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 28.72
Quick Ratio 24.65
Altman-Z 36.76
F-Score4
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)173.55%
Cap/Depr(5y)133.26%
Cap/Sales(3y)513.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.01%
EPS Next Y33.33%
EPS Next 2Y35.81%
EPS Next 3Y57.51%
EPS Next 5Y34.42%
Revenue 1Y (TTM)-69.78%
Revenue growth 3Y42.37%
Revenue growth 5YN/A
Sales Q2Q%-59.4%
Revenue Next Year-48.87%
Revenue Next 2Y27.94%
Revenue Next 3Y59.87%
Revenue Next 5Y37.88%
EBIT growth 1Y-117.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.36%
EBIT Next 3Y78.89%
EBIT Next 5Y50.58%
FCF growth 1Y-87.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.88%
OCF growth 3YN/A
OCF growth 5YN/A

URANIUM ENERGY CORP / U6Z.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of URANIUM ENERGY CORP (U6Z.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to U6Z.DE.


What is the valuation status of URANIUM ENERGY CORP (U6Z.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to URANIUM ENERGY CORP (U6Z.DE). This can be considered as Overvalued.


What is the profitability of U6Z stock?

URANIUM ENERGY CORP (U6Z.DE) has a profitability rating of 1 / 10.


How financially healthy is URANIUM ENERGY CORP?

The financial health rating of URANIUM ENERGY CORP (U6Z.DE) is 8 / 10.